Completed
Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT02277197
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck, +8 more
- Locations
-
- UPMC Presbyterian Pittsburgh, Pennsylvania, United States
- Hillman Cancer Center Pittsburgh, Pennsylvania, United States
- UPMC Shadyside Pittsburgh, Pennsylvania, United States